Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2B
Enterprise Value2.74B
P/E Ratio-10.89
PEG Ratio0.18
Price/Sales Ratio2.39
Price/Book Ratio1.39
Enterprise/Revenue3.08
Enterprise/EBITDA-29.9

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.22
Operating Margin-0.22
AD

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.12

Income Statement

Revenue940.19M
Revenue/Share8.46
Gross Profit222.07M
EBITDA84.1M
Net Income-82.39M
Diluted EPS-0.73

Balance Sheet

Total Cash284.33M
Total Cash/Share2.53
Total Debt865.12M
Total Debt/Equity0.53
Current Ratio2.04
Book Value Per Share14.44

Price History

52-Week Change-4.98
52-Week High28.29
52-Week Low13.71
Moving Average 50 Days23.35
Moving Average 200 Days20.84

Statistics

Average Volume7.44M
Shares Outstanding113.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.06
Last Split FactorN/A
Last Split DateN/A
AD